About Timothy Haines
Form D filings for Venatorx Pharmaceuticals from 2022 to 2023 list Timothy Haines as director.
Timothy Haines first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Haines in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timothy Haines works with at each company, as listed on that company's latest Form D.
Venatorx Pharmaceuticals, Inc. · Form D/A, Jul 13, 2023
TH
Tomas Heyman
Director
CB
Christopher Burns
President and director
DP
Daniel Pevear
Executive officer
AM
Anthony Meehan
Executive officer
SP
Sergei Petukhov
Director
MH
Martin Heidecker
Director